Orin Hirschman 13D and 13G filings for Evoke Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-05-06 4:20 pm Purchase | 2021-04-30 | 13G | Evoke Pharma, Inc. EVOK | Orin Hirschman | 11,814 5.300% | 1,862 (+18.71%) | Filing |
| 2021-03-25 6:28 pm Sale | 2021-03-19 | 13G | Evoke Pharma, Inc. EVOK | Orin Hirschman | 9,952 4.400% | -1,853 (-15.70%) | Filing |
| 2021-01-20 07:20 am Purchase | 2021-01-14 | 13G | Evoke Pharma, Inc. EVOK | Orin Hirschman | 11,806 5.300% | 11,806 (New Position) | Filing |